Use of biomaterials in the surgical regenerative treatment of peri-implantitis: systematic review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i12.20454

Keywords:

Dentistry; Dental Implants; Osseointegration; Peri-implantitis; Bone Regeneration; Biomaterials.

Abstract

The aim of this study was to review the scientific literature regarding the effectiveness of different biomaterials in the regenerative treatment of peri-implantitis. A systematic literature search was performed in PubMed/Medline, Web of Science, Science Direct, Embase, and the Cochrane Collaboration Library. Studies on the use of biomaterials in the regenerative treatment of peri-implantitis were selected. The search strategy retrieved 253 articles. After selection, six articles met all inclusion criteria and were included in the present systematic review. The studies showed that an initial therapeutic approach consisting of plaque control and implant surface decontamination and subsequent surgery for biomaterial placement were essential for the successful regenerative treatment of peri-implantitis defects. Analysis of all biomaterials used in surgical regenerative treatment showed that bovine bone grafts provided superior outcomes in terms of new bone formation compared to autogenous grafts and nanocrystalline hydroxyapatite. It is important to note that porous titanium granules have emerged as a promising biomaterial for the regenerative treatment of peri-implantitis. In conclusion, biomaterials are promising for the treatment of peri-implant bone defects and the number of in silico biomaterials that can provide treatment of excellence to patients with this condition is expected to increase in the near future.

References

Rotenberg SA, Steiner R, Tatakis DN. Collagen-Coated Bovine Bone in Peri-implantitis Defects: A Pilot Study on a Novel Approach. Int J Oral Maxillofac Implants. 2016; 31(3):701-707. doi: 10.11607 / jomi.4303.

Arab H, Shiezadeh F, Moeintaghavi A, Anbiaei N, Mohamadi S. Comparison of Two Regenerative Surgical Treatments for Peri-Implantitis Defect using Natix Alone or in Combination with Bio-Oss and Collagen Membrane. J Long Term Eff Med Implants. 2016; 26(3): 199-2014. doi: 10.1615

Heitz-Mayfield LJ, Mombelli A. The therapy of peri-implantitis: a systematic review. Int J Oral Maxillofac Implants. 2014; 29:325-345. doi: 10.11607 / jomi.2014suppl.g5.3

Mccrea SJ. Advanced peri-implantitis cases with radical surgical treatment. J Periodontal Implant Sci. 2014; 44(1): 39-47. doi: 10.5051 / jpis.2014.44.1.39

Kim JJ, Lee JH, Kim JC, Lee JB, Yeo IL. Biological Responses to the Transitional Area of Dental Implants: Material- and Structure-Dependent Responses of Peri-Implant Tissue to Abutments. Materials (Basel). 2019; 13(1): 72. doi: 10.3390/ma13010072.

Noriko M, Fumito M, Yasuo T, Chihiro A, Yuichi I, Ichiro N. Intraindividual variation in core microbiota in peri-implantitis and periodontitis. Sci Rep. 2014; 4(6602):1-10. doi: 10.1038 / srep06602

AAP, American Academy of Periodontology. Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013; 84: 436-443. doi:10.1902 / jop.2013.134001.

Alqahtani F, Alqhtani N, Divakar DD, Shetty SB, Shetty B, Alkhtani F. Self-rated peri-implant oral symptoms and clinicoradiographic characteristics in Narghile-smokers, cigarette-smokers, and nonsmokers with peri-implantitis. Clin Implant Dent Relat Res. 2019; 21(6): 1235-1240. doi: 10.1111/cid.12864.

Faggion CMJ, Listl S, Frühauf N, Chang HJ, Tu YK. A systematic review and Bayesian network meta-analysis of randomized clinical trials on non-surgical treatments for peri-implantitis. J Clin Periodontol. 2014; 41(10): 1015-1025. doi: 10.1111 / jcpe.12292.

Lopes D, Martins-Cruz C, Oliveira MB, Mano JF. Bone physiology as inspiration for tissue regenerative therapies. Biomaterials. 2018; 185: 240-275. doi: 10.1016/j.biomaterials.2018.09.028.

Aghazadeh A, Persson GR, Renvert S. A single-centre randomized controlled clinical trial on the adjunct treatment of intra-bony defects with autogenous bone or a xenograft: results after 12 months. J Clin Periodontol. 2012; 39(7): 666-673. doi: 10.1111/j.1600-051X.2012.01880.x.

Wiltfang J, Zernial O, Behrens E, Schlegel A, Warnke PH, Becker ST. Regenerative treatment of peri-implantitis bone defects with a combination of autologous bone and a demineralized xenogenic bone graft: a series of 36 defects. Clin Implant Dent Relat Res. 2012; 14(3): 421-427. doi: 10.1111/j.1708-8208.2009.00264.x.

Roos-Jansaaker AM, Persson GR; Lindahl C, Renvert S. Surgical treatment of periimplantitis using a bone substitute with or without a resorbable membrane: a 5-year follow-up. J Clin Periodontol. 2014; 41(11): 1108-1114. doi: 10.1111/ jcpe.12308.

Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 21;6(7):e1000097. doi: 10.1136/bmj.m2632

Higgins JPT, Deeks J, Altman DG., & on behalf of the Cochrane Statistical Methods Group (2011). Chapter 8: Assessing risk of bias in included studies. In J. P. T. Higgins, & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011.

Schwarz F, Bieling K, Latz T, Nuesry E, Becker J. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series. J Clin Periodontol. 2006; 33(7): 491-499. doi: 10.1111/j.1600-051X.2006.00936.x.

Romanos GE, Nentwig GH. Regenerative therapy of deep peri-implant infrabony defects after CO2 laser implant surface decontamination. Int J Periodontics Restorative Dent. 2008; 28(3): 245-255.

Guler B, Uraz A, Yalim M, Bozkaya S. The comparison of porous titanium granule and xenograft in the surgical treatment of peri-implantitis: a prospective clinical study. Clin Implant Dent Relat Res. 2017; 19(2): 316-327. doi: 10.1111 / cid.12453.

Roccuzzo M, Gaudioso L, Lungo M, Dalmasso P. Surgical therapy of single peri-implantitis intrabony defects, by means of deproteinized bovine bone mineral with 10% collagen. J Clin Periodontol. 2016; 43(3): 311-318. doi: 10.1111/ jcpe.12516.

Mercado F, Hamlet S, Ivanovski S. Regenerative surgical therapy for peri-implantitis using deproteinized bovine bone mineral with 10% collagen, enamel matrix derivative and Doxycycline-A prospective 3-year cohort study. Clin Oral Implants Res. 2018; 29(6):583-591. doi: 10.1111/clr.13256.

Alassy H, Parachuru P, Wolff L. Peri-Implantitis Diagnosis and Prognosis Using Biomarkers in Peri-Implant Crevicular Fluid: A Narrative Review. Diagnostics (Basel). 2019; 9(4): .214. doi: 10.3390/diagnostics9040214.

Bassetti M, Schär D, Wicki B, Eick S, Ramseier CA, Arweiler NB. Anti-infective therapy of periimplantitis with adjunctive local drug delivery or photodynamic therapy: 12-month outcomes of a randomized controlled clinical trial. Clin Oral Implants Res. 2013; 25(3):279-287. doi: 10.1111/clr.12155.

Xu Y, Li H, Wu J, Yang Q, Jiang D, Qiao B. Polydopamine-induced hydroxyapatite coating facilitates hydroxyapatite/polyamide 66 implant osteogenesis: an in vitro and in vivo evaluation. Int J Nanomedicine. 2018; 13: 8179-8193.

Downloads

Published

20/09/2021

How to Cite

PINHEIRO, J. C.; NETO, B. da F. .; LIMA, J. G. da C. .; SILVA, Y. A. .; SILVA, G. G. da .; MORAIS, I. P. S. .; ALMEIDA, D. R. de M. F. . Use of biomaterials in the surgical regenerative treatment of peri-implantitis: systematic review. Research, Society and Development, [S. l.], v. 10, n. 12, p. e275101220454, 2021. DOI: 10.33448/rsd-v10i12.20454. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/20454. Acesso em: 22 nov. 2024.

Issue

Vol. 10 No. 12

Section

Health Sciences

License

Copyright (c) 2021 Juliana Campos Pinheiro; Braz da Fonseca Neto; Jabes Gennedyr da Cruz Lima; Yunes Araújo Silva; Gabriel Gomes da Silva; Isaac Pessoa Santiago Morais; Dennys Ramon de Melo Fernandes Almeida

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.